Life after treatment for follicular lymphoma brings long-term physical and emotional challenges, including immune system ...

The author of the ‘Leonard List’ that highlights emerging hematologic research to be presented at annual ASH meetings is also ...

Wojciech Jurczak, MD, PhD, ​​discusses nemtabrutinib and its development for the treatment of follicular lymphoma.

It usually responds well to treatment and is often cured. About one in five people with lymphoma have follicular lymphoma. This is a slow-growing form that mainly affects older adults. It might ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

TAZVERIK ® is a registered trademark of Epizyme Inc., an Ipsen company.

Chugai Pharmaceutical has launched Lunsumio (mosunetuzumab) in Japan for patients with relapsed or refractory follicular ...

diffuse large b-cell lymphoma (DLBCL), large Bcell lymphoma, and follicular lymphoma (FL); and Tivdak for adult patients with recurrent/metastatic cervical cancer with disease progression on or ...